Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1343535

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to prepare for a covid-19 booster vaccination programme before winter 2021.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	27028
answer	answer is ministerial correction date of answer 08/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>Final decisions on the timing and scope of the booster programme, as well as cohorts and eligibility, will be made later in the year, informed by further independent advice from the JCVI. NHS England and NHS Improvement are asking all local systems to develop detailed plans to ensure they are ready to deliver a booster programme from the start of September should this be required.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/07/2021 16:59:47 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1409 label Biography information for Mr Gregory Campbell

1343538

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus and Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether covid-19 booster vaccines and flu vaccines will be delivered (a) at the same time and (b) in pharmacies.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	27158
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI recommends a two staged approach is recommended, with those in the first stage offered a booster and flu vaccine as soon as possible from September. Those in the second stage would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing and scope of the vaccine booster programme, as well as cohorts and eligibility, will be made later in the year, informed by further independent advice from the JCVI. This includes further data on the durability of protection from vaccines, data supplied by manufacturers and clinical trial data regarding COVID-19 vaccine and flu vaccine coadministration. On 1 July, NHS England and NHS Improvement wrote to primary care providers, including community pharmacies, outlining the JCVI’s interim advice to allow local planning to begin.</p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/07/2021 16:05:46 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1343576

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the covid-19 vaccine status of (a) people who die within 28 days of a positive covid-19 test and (b) new covid-19 infections.
tabling member constituency	Gravesham
tabling member printed	Adam Holloway
uin	27056
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>Public Health England (PHE) monitors the number of people who have been admitted to hospital and died from COVID-19 who have received one or two doses of the vaccine and will publish this data in due course. This includes the number of new cases of COVID-19 infection following vaccination.</p><p>PHE has not made a specific assessment of the potential effect of publishing information on the COVID-19 vaccine status of people who die within 28 days of a positive COVID-19 test and new COVID-19 infections on rates of vaccine uptake.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 27057 question first answered 13/07/2021 12:41:51 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 12675 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1522 label Biography information for Adam Holloway

1343577

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of publishing information on the covid-19 vaccine status of (a) people who die within 28 days of a positive Covid test and (b) new covid-19 infections on rates of vaccine uptake.
tabling member constituency	Gravesham
tabling member printed	Adam Holloway
uin	27057
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>Public Health England (PHE) monitors the number of people who have been admitted to hospital and died from COVID-19 who have received one or two doses of the vaccine and will publish this data in due course. This includes the number of new cases of COVID-19 infection following vaccination.</p><p>PHE has not made a specific assessment of the potential effect of publishing information on the COVID-19 vaccine status of people who die within 28 days of a positive COVID-19 test and new COVID-19 infections on rates of vaccine uptake.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 27056 question first answered 13/07/2021 12:41:52 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 12676 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1522 label Biography information for Adam Holloway

1343608

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress he has made on research into the efficacy of a third booster dose of a covid-19 vaccine for immunocompromised and immunosuppressed groups.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	27084
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The COV-BOOST study was commissioned through the National Institute for Health Research and will provide vital data on the impact of a third dose on patients’ immune responses. Initial findings are expected in September. To fully understand how COVID-19 vaccines respond as a booster dose they must first be studied in people with a fully functioning immune system.</p><p>UK Research and Innovation is providing £4 million towards the OCTAVE study examining COVID-19 vaccine responses in clinically at-risk groups, including immunocompromised patients.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/07/2021 15:40:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1538 label Biography information for Rosie Cooper

1343625

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will include people with asthma in his autumn 2021 programme of booster covid-19 vaccinations.
tabling member constituency	Chipping Barnet
tabling member printed	Theresa Villiers
uin	27050
answer	answer is ministerial correction date of answer 08/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI advises a two staged approach, with individuals in offered a booster, and flu vaccine as soon as possible from September. Individuals in stage two should be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. Adults aged over 50 years old and those aged 16 to 49 years old who are in an influenza or COVID-19 at-risk group are included in stage two. Influenza at-risk groups are defined in the Green Book include some sufferers of chronic respiratory disease such as asthma.</p><p>Final decisions on the timing and scope of the vaccine booster programme, as well as cohorts and eligibility, will be made later in the year, informed by further independent advice from the JCVI.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/07/2021 17:01:28 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1500 label Biography information for Theresa Villiers

1343626

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will include people on GP lists for flu vaccinations in his autumn 2021 programme of booster covid-19 vaccinations.
tabling member constituency	Chipping Barnet
tabling member printed	Theresa Villiers
uin	27051
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI advises a two staged approach, with individuals in stage one offered a booster and flu vaccine, as soon as possible from September. Individuals at stage two would be offered a COVID-19 booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. Adults aged over 50 years old and those aged 16 to 49 years old who are in an influenza or COVID-19 at-risk group, are included in stage two.</p><p>Final decisions on the timing and scope of the booster programme, as well as cohorts and eligibility, will be made later in the year, informed by further independent advice from the JCVI.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/07/2021 16:00:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1500 label Biography information for Theresa Villiers

1343631

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will provide an update on his plans to conduct research into the efficacy of a third covid-19 vaccine booster dose for immunocompromised and immunosuppressed groups.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	27122
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The COV-BOOST study was commissioned through the National Institute for Health Research and will provide vital data on the impact of a third dose on patients’ immune responses. Initial findings are expected in September. To fully understand how COVID-19 vaccines respond as a booster dose they must first be studied in people with a fully functioning immune system.</p><p>UK Research and Innovation is providing £4 million towards the OCTAVE study examining COVID-19 vaccine responses in clinically at-risk groups, including immunocompromised patients.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/07/2021 15:36:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3960 label Biography information for Henry Smith

1343655

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people without an NHS number are able to be certified as vaccinated against covid-19.
tabling member constituency	Luton North
tabling member printed	Sarah Owen
uin	27330
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>A National Health Service number is needed for individuals to demonstrate their COVID-19 vaccination status via the NHS App, through the NHS website or via letters from the NHS, which can be requested by calling 119. Anyone can register with a general practitioner (GP) practice to get an NHS number. It is free to register and proof of address or immigration status, ID or an NHS number is not needed. A registration letter will arrive in the post containing an NHS number.</p><p>Individuals who do not have an NHS number or are not registered with a GP are still entitled to free COVID-19 vaccinations.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 14:11:04 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 12663 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4777 label Biography information for Sarah Owen

1343693

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether AstraZeneca plans to apply to European Medicines Agency for approval of the covid-19 vaccine manufactured by the Serum Institute in India in order for people who received that vaccine to have their covid-19 vaccinations recognised by EU countries.
tabling member constituency	North Down
tabling member printed	Stephen Farry
uin	27366
answer	answer is ministerial correction date of answer 09/07/2021 answer text <p>Licencing applications to the European Medicines Agency (EMA) are a matter for individual pharmaceutical companies.</p><p>The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield, branded vaccines which are the same as the COVID-19 University of Oxford/AstraZeneca vaccine. All SII-made doses approved by the United Kingdom regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK.</p><p>All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria. The EMA has authorised the Vaxzevria vaccine and it is therefore recognised by the European Union.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/07/2021 13:11:01 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4856 label Biography information for Stephen Farry